avarol-3'-thiosalicylate

structure in first source

Networked: 2 relevant articles (0 outcomes, 1 trials/studies)

1.	Cañadas, Sixta: 1 article (10/2016)
2.	García-Font, Nuria: 1 article (10/2016)
3.	Iodice, Carmine: 1 article (10/2016)
4.	Marco-Contelles, José: 1 article (10/2016)
5.	Oset-Gasque, María Jesús: 1 article (10/2016)
6.	Pejin, Boris: 1 article (10/2016)
7.	Tommonaro, Giuseppina: 1 article (10/2016)
8.	Vitale, Rosa Maria: 1 article (10/2016)
9.	Amigó, M: 1 article (10/2007)
10.	De Rosa, S: 1 article (10/2007)

1.	Psoriasis (Pustulosis Palmaris et Plantaris) 10/01/2007 - "The aim of this study was to evaluate the in vitro and in vivo pharmacological behaviour of the derivative avarol-3'-thiosalicylate (TA) on some inflammatory parameters related to the pathogenesis of psoriasis. "
2.	Neuroblastoma 10/21/2016 - "This paper describes the synthesis and in vitro biological evaluation of avarol-3'-thiosalicylate (TAVA) and thiosalycil-prenyl-hydroquinones (TPHs), as non hepatotoxic anticholinesterasic agents, showing a good neuroprotective effect on the decreased viability of SHSY5Y human neuroblastoma cells induced by oligomycin A/rotenone and okadaic acid. "